<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Microbiol</journal-id><journal-id journal-id-type="publisher-id">bjm</journal-id><journal-title-group><journal-title>Brazilian Journal of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1517-8382</issn><issn pub-type="epub">1678-4405</issn><publisher><publisher-name>Sociedade Brasileira de Microbiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26273283</article-id><article-id pub-id-type="pmc">4507560</article-id><article-id pub-id-type="doi">10.1590/S1517-838246220140553</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics and Molecular Microbiology</subject></subj-group></article-categories><title-group><article-title>Platelets can be a biological compartment for the Hepatitis C
Virus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ariede</surname><given-names>Jovita Ramos</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Pardini</surname><given-names>Maria In&#x000ea;s de Moura Campos</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Giovanni Faria</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Grotto</surname><given-names>Rejane Maria Tommasini</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff03">3</xref><xref ref-type="aff" rid="aff04">4</xref><xref rid="c01" ref-type="corresp"/></contrib></contrib-group><aff id="aff01"><label>1</label>Universidade Estadual Paulista, Divis&#x000e3;o Hemocentro, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brasil, Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Pesquisa e
Desenvolvimento (Biotecnologia M&#x000e9;dica), Divis&#x000e3;o Hemocentro, Faculdade de
Medicina de Botucatu, Universidade Estadual Paulista "J&#x000fa;lio de Mesquita Filho",
Botucatu, SP, Brasil.</aff><aff id="aff02"><label>2</label>Universidade Estadual Paulista, Departamento de Cl&#x000ed;nica M&#x000e9;dica, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brasil, Departamento de Cl&#x000ed;nica M&#x000e9;dica, Faculdade de
Medicina de Botucatu, Universidade Estadual Paulista "J&#x000fa;lio de Mesquita Filho",
Botucatu, SP, Brasil.</aff><aff id="aff03"><label>3</label>Universidade Estadual Paulista, Divis&#x000e3;o Hemocentro, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brasil, Laborat&#x000f3;rio de Biologia Molecular, Divis&#x000e3;o
Hemocentro, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista
"J&#x000fa;lio de Mesquita Filho", Botucatu, SP, Brasil.</aff><aff id="aff04"><label>4</label>Universidade Estadual Paulista, Faculdade de Ci&#x000ea;ncias Agron&#x000f4;micas, Fazenda Experimental de Lageado, Universidade Estadual Paulista, Botucatu, SP, Brasil, Departamento Bioprocessos e Biotecnologia,
Faculdade de Ci&#x000ea;ncias Agron&#x000f4;micas, Fazenda Experimental de Lageado, Universidade
Estadual Paulista "J&#x000fa;lio de Mesquita Filho", Botucatu, SP, Brasil.</aff><author-notes><corresp id="c01">Send correspondence to R.M.T. Grotto. Laborat&#x000f3;rio de Biologia
Molecular, Divis&#x000e3;o Hemocentro, Faculdade de Medicina de Botucatu, Universidade
Estadual Paulista "J&#x000fa;lio de Mesquita Filho", Botucatu, SP, Brazil. E-mail:
<email>regrotto@fca.unesp.br</email>.</corresp><fn id="fn01" fn-type="other"><p>Associate Editor: Maur&#x000ed;cio Lacerda Nogueira</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><volume>46</volume><issue>2</issue><fpage>627</fpage><lpage>629</lpage><history><date date-type="received"><day>02</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>16</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015, Sociedade Brasileira de
Microbiologia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>All the content of the journal, except where otherwise noted, is
licensed under a Creative Commons License CC BY-NC.</license-p></license></permissions><abstract><p>Although HCV has hepatic tropism, the presence of the virus in extra-hepatic
compartments has been well documented. Platelets have been described as carriers
of the virus in the circulation and may be a natural reservoir for the virus.
However, few studies have been performed to evaluate the levels of HCV RNA in
plasma and platelets are equal or differ in some way. Therefore, the aim of this
study was to perform a comparative evaluation of the stability of HCV RNA in
plasma and isolated platelets. Four aliquots of whole plasma obtained from
patients infected with HCV were incubated at 37 &#x000b0;C for 0, 48, 96 and 144 h.
After incubation, the plasma and platelet pellet was obtained from each aliquot.
Viral RNA in plasma and platelets was quantified by q-PCR. The results showed a
decrease in HCV RNA levels in plasma with incubation time. However, platelet HCV
RNA levels were stable up to 144 h incubation. The results of this study showed
that HCV RNA in platelets, although at lower concentrations than in plasma, is
preserved from degradation over time, suggesting that the virus may persist
longer in the body when associated with platelets, which could have an impact on
the efficiency of antiviral therapy.</p></abstract><kwd-group><kwd>Hepatitis C Virus</kwd><kwd>platelets</kwd><kwd>viral load</kwd><kwd>virological relapse</kwd></kwd-group><counts><fig-count count="0"/><table-count count="1"/><equation-count count="0"/><ref-count count="14"/><page-count count="3"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The study of the viral kinetics of infection by the hepatitis C virus (HCV) still
presents difficulties due to lack of experimental models (<xref rid="B12" ref-type="bibr">Penin <italic>et al.</italic>, 2004</xref>). HCV replication
models show that adaptive mutations frequently occur regardless of virus variants
and can promote virus replication (<xref rid="B02" ref-type="bibr">Bartosh and
Cosset, 2006</xref>). Thus, the pathogenesis of HCV infection differs from
classical models of infection by viruses, reflecting the adaptation to humans (<xref rid="B01" ref-type="bibr">Alter and Houghton, 2001</xref>).</p><p>In the course of chronic infection by the virus, phases of high-level viremia may
alternate with phases of low-level viremia or undetectable virus in plasma or serum
(<xref rid="B07" ref-type="bibr">Esp&#x000ed;rito-Santo <italic>et al.</italic>,
2013</xref>). However, studies have demonstrated that HCV is not only found on
hepatocytes, but also plasma and/or serum of infected patients (<xref rid="B08" ref-type="bibr">Fujiwara <italic>et al.</italic>, 2013</xref>). Although the
hepatocyte is the major target cell of HCV, viral RNA has been found in extrahepatic
compartments (<xref rid="B14" ref-type="bibr">Schmidt <italic>et al.</italic>,
1997</xref>; <xref rid="B03" ref-type="bibr">Castillo <italic>et al.</italic>,
2005</xref>; <xref rid="B04" ref-type="bibr">Chary <italic>et al.</italic>,
2012</xref>). Furthermore, studies have demonstrated that in individuals
infected with HCV, viral RNA is associated with platelets, which are carriers of the
virus in circulation (<xref rid="B09" ref-type="bibr">Hamaia <italic>et
al.</italic>, 2001</xref>; <xref rid="B06" ref-type="bibr">De Almeida <italic>et
al.</italic>, 2009</xref>; <xref rid="B11" ref-type="bibr">Padovani
<italic>et al.</italic>, 2013</xref>).</p><p>Few studies have been performed to evaluate the amount of viral RNA in other
biological compartments, so it is not yet well established whether the
quantification of HCV RNA in plasma or serum differs from that found in other
biological compartments (<xref rid="B09" ref-type="bibr">Hamaia <italic>et
al.</italic>, 2001</xref>; <xref rid="B04" ref-type="bibr">Chary <italic>et
al.</italic>, 2012</xref>; <xref rid="B07" ref-type="bibr">Esp&#x000ed;rito-Santo
<italic>et al.</italic>, 2013</xref>).</p><p>Therefore, the aim of this study was to perform a comparative evaluation of the
stability of HCV RNA in plasma and isolated platelets.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><p>Aliquots of ethylenediaminetetraacetic acid-anticoagulated peripheral venous blood
were collected from HCV-infected patients who were antiviral treatment-na&#x000ef;ve and
that would initiate antiviral treatment during the development of the study and had
HBV- and HIV-negative serology and the absence of other hepatic diseases, seen at
the Department of Internal Medicine, Gastroenterology Division, Botucatu Medical
School, Sao Paulo State University, UNESP, Botucatu, SP, Brazil.</p><p>The study was approved by the Research Ethics Committee of Botucatu Medical School,
UNESP (number 3764-2011).</p><p>The blood sample was centrifuged for 3 min at 1312 g to obtain platelet-rich plasma,
which was separated into four aliquots. The first one was centrifuged for 5 min at
1600 g to pellet the platelets. The supernatant was removed, and the platelet pellet
was washed with 0.9% NaCl five times.</p><p>The same procedure was performed with the other three aliquots, after incubation for
48, 96 and 144 h, respectively, at 37 &#x000b0;C in an Incubator Shaker (New Brunswick
Scientific, USA) with horizontal mixing at 30 g until RNA quantification.</p><p>HCV RNA quantification in plasma and platelets was performed according <xref rid="B11" ref-type="bibr">Padovani <italic>et al.</italic> (2013)</xref>.</p><p>HCV genotyping was performed in plasma and platelet samples using 5&#x02032; UTR and core
genomic region according to <xref rid="B10" ref-type="bibr">Levada <italic>et
al.</italic> (2010)</xref>.</p><p>This experiment was performed in triplicate. Two negative controls were used in the
experiment according to all <xref rid="B11" ref-type="bibr">Padovani <italic>et
al.</italic> (2013)</xref>. The first was performed with platelet pellet and
these were incubated with the HCV-negative serum, and the second consisted in an
empty tube without platelets, and this tube was incubated with the same set of serum
used in test samples.</p><p>After the last washed, the supernatant was used as source to RT-PCR for HCV
identification according <xref rid="B10" ref-type="bibr">Levada <italic>et
al.</italic> (2010)</xref> for evaluate any possibility of contamination
with serum HCV.</p></sec><sec sec-type="results"><title>Results</title><p>The samples were obtained from patients with a mean age of 57.5 years [IQR
(35.5&#x02013;87.5)], two men and a woman. All patients presented with portal fibrosis in
F2/F3 according to the METAVIR score.</p><p>
<xref rid="t01" ref-type="table">Table 1</xref> summarizes the HCV RNA levels in
plasma and platelets for three replicates performed according to the processing
time: 0 (immediately after collection), and after 48, 96, 144 h of incubation at 37
&#x000b0;C.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title>HCV RNA Levels in plasma and platelets according to processing time: 0 h
(immediately after collection) and after 48, 96, 144 h of incubation at 37
&#x000b0;C.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Plasma</th><th valign="bottom" align="center" rowspan="1" colspan="1">0 h (Log)</th><th valign="bottom" align="center" rowspan="1" colspan="1">48 h (Log)</th><th valign="bottom" align="center" rowspan="1" colspan="1">96 h (Log)</th><th valign="bottom" align="center" rowspan="1" colspan="1">144 h (Log)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Replicate 1</td><td valign="top" align="center" rowspan="1" colspan="1">6.08</td><td valign="top" align="center" rowspan="1" colspan="1">4.74</td><td valign="top" align="center" rowspan="1" colspan="1">3.61</td><td valign="top" align="center" rowspan="1" colspan="1">2.82</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Replicate 2</td><td valign="top" align="center" rowspan="1" colspan="1">7.75</td><td valign="top" align="center" rowspan="1" colspan="1">7.64</td><td valign="top" align="center" rowspan="1" colspan="1">3.55</td><td valign="top" align="center" rowspan="1" colspan="1">3.39</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Replicate 3</td><td valign="top" align="center" rowspan="1" colspan="1">7.76</td><td valign="top" align="center" rowspan="1" colspan="1">7.22</td><td valign="top" align="center" rowspan="1" colspan="1">4.54</td><td valign="top" align="center" rowspan="1" colspan="1">2.31</td></tr><tr><td colspan="5" valign="top" align="left" rowspan="1">
<hr/>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Platelets</td><td valign="top" align="center" rowspan="1" colspan="1">0 h (Log)</td><td valign="top" align="center" rowspan="1" colspan="1">48 h (Log)</td><td valign="top" align="center" rowspan="1" colspan="1">96 h (Log)</td><td valign="top" align="center" rowspan="1" colspan="1">144 h (Log)</td></tr><tr><td colspan="5" valign="top" align="left" rowspan="1">
<hr/>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Replicate 1</td><td valign="top" align="center" rowspan="1" colspan="1">3.13</td><td valign="top" align="center" rowspan="1" colspan="1">3.20</td><td valign="top" align="center" rowspan="1" colspan="1">3.41</td><td valign="top" align="center" rowspan="1" colspan="1">3.60</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Replicate 2</td><td valign="top" align="center" rowspan="1" colspan="1">4.94</td><td valign="top" align="center" rowspan="1" colspan="1">5.82</td><td valign="top" align="center" rowspan="1" colspan="1">5.88</td><td valign="top" align="center" rowspan="1" colspan="1">5.92</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Replicate 3</td><td valign="top" align="center" rowspan="1" colspan="1">4.65</td><td valign="top" align="center" rowspan="1" colspan="1">5.50</td><td valign="top" align="center" rowspan="1" colspan="1">5.77</td><td valign="top" align="center" rowspan="1" colspan="1">5.87</td></tr></tbody></table></table-wrap><p>The results showed a decrease in plasma HCV RNA levels with incubation time. However,
platelet HCV RNA levels were stable up to 144 h incubation.</p><p>The HCV genotype present in plasma and platelets was concordant (genotype 3a).</p><p>No contaminations were detected in the experiments.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The results of our study demonstrate that HCV RNA in platelets, although at a lower
concentration than in plasma, is more preserved from degradation over time (<xref rid="t01" ref-type="table">Table 1</xref>), suggesting that the virus may
persist longer in the body when associated with platelets.</p><p>These findings suggest the presence of HCV in platelets as a biological compartment
of reservation. <xref rid="B09" ref-type="bibr">Hamaia <italic>et al.</italic>
(2001)</xref> have suggested that, besides the possibility of specific surface
molecules mediating HCV binding to platelets, the morphology of these cells could
result in the nonspecific adsorption of HCV on the platelet surface. Based on this
hypothesis, probably higher viral load values could be associated with the detection
of HCV in platelets.</p><p>The nature of HCV binding to cells is not well understood and a number of potential
receptors have been investigated (<xref rid="B02" ref-type="bibr">Bartosh,
2006</xref>). The hypervariable region 1 of HCV E2 envelope glycoproteins
appears to play a central role in the HCV binding to cells, although CD81 has been
postulated as a major HCV receptor (<xref rid="B05" ref-type="bibr">De Almeida
<italic>et al.</italic>, 2007</xref>; Marincola and Alter, 2013).</p><p>In this line of reasoning, the platelets can function as an important compartment for
the virus and sequester the virions from the circulation, contributing to viral
persistence and viral escape from the host immune system, which may have an impact
on the efficiency of antiviral therapy (<xref rid="B01" ref-type="bibr">Alter and
Houghton, 2001</xref>).</p><p>Further studies with an increase number of samples in this population are necessary
to better evaluate the dynamics of HCV RNA preservation of platelets over time.</p><p>The results of this study open perspectives for viruses associated with platelets to
be the target of therapeutic intervention strategies, since this type of virus is
more efficiently sequestered in this biological compartment than in plasma.</p></sec></body><back><ack><title>Acknowledgments</title><p>This research was supported by the State Secretariat of Health of Sao Paulo - State
Program of Viral Hepatitis and FAPESP (Sao Paulo Research Foundation).</p></ack><ref-list><title>References</title><ref id="B01"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alter</surname><given-names>JJ</given-names></name><name><surname>Houghton</surname><given-names>M</given-names></name></person-group><year>2001</year><article-title>Clinical Medical Research Award Hepatitis C virus and eliminating
post-transfusion hepatitis</article-title><source>Nat Med</source><volume>6</volume><fpage>1082</fpage><lpage>1086</lpage><pub-id pub-id-type="pmid">11017126</pub-id></element-citation></ref><ref id="B02"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartosh</surname><given-names>B</given-names></name><name><surname>Cosset</surname><given-names>FL</given-names></name></person-group><year>2006</year><article-title>Cell entry of hepatitis C virus</article-title><source>Virology</source><volume>348</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16455127</pub-id></element-citation></ref><ref id="B03"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>I</given-names></name><name><surname>Rodr&#x000ed;guez-I&#x000f1;igo</surname><given-names>E</given-names></name><name><surname>Bartolom&#x000e9;</surname><given-names>J</given-names></name><etal/></person-group><year>2005</year><article-title>Hepatitis C virus replicates in peripheral blood mononuclear
cells of patients with occult hepatitis C virus infection</article-title><source>Gut</source><volume>54</volume><fpage>682</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">15831916</pub-id></element-citation></ref><ref id="B04"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chary</surname><given-names>A</given-names></name><name><surname>Winters</surname><given-names>MA</given-names></name><name><surname>Eisen</surname><given-names>R</given-names></name><etal/></person-group><year>2012</year><article-title>Quantitation of hepatitis C virus RNA in peripheral blood
mononuclear cells in HCV-monoinfection and
HIV/HCV-coinfection</article-title><source>J Med Virol</source><volume>84</volume><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">22246828</pub-id></element-citation></ref><ref id="B05"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Almeida</surname><given-names>AJ</given-names></name><name><surname>Campos-de-Magalh&#x000e3;es</surname><given-names>M</given-names></name><name><surname>Brand&#x000e3;o-Mello</surname><given-names>CE</given-names></name><etal/></person-group><year>2007</year><article-title>Detection of hepatitis C virus in platelets: evaluating its
relationship to viral and host factors</article-title><source>Hepatogastroenterology</source><volume>54</volume><fpage>964</fpage><lpage>968</lpage><pub-id pub-id-type="pmid">17591104</pub-id></element-citation></ref><ref id="B06"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Almeida</surname><given-names>AJ</given-names></name><name><surname>Campos-De-Magalh&#x000e3;es</surname><given-names>M</given-names></name><name><surname>Brand&#x000e3;o-Mello</surname><given-names>CE</given-names></name><etal/></person-group><year>2009</year><article-title>Detection of hepatitis C virus in platelets: evaluating its
relationship to antiviral therapy outcome</article-title><source>Hepatogastroenterology</source><volume>56</volume><fpage>429</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">19579615</pub-id></element-citation></ref><ref id="B07"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esp&#x000ed;rito-Santo</surname><given-names>MP</given-names></name><name><surname>Brand&#x000e3;o-Mello</surname><given-names>CE</given-names></name><name><surname>Marques</surname><given-names>VA</given-names></name><etal/></person-group><year>2013</year><article-title>Analysis of hepatitis C virus (HCV) RNA load in platelets of
HCV-monoinfected patients receiving antiviral therapy</article-title><source>Ann Hepatol</source><volume>12</volume><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">23619253</pub-id></element-citation></ref><ref id="B08"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Allison</surname><given-names>RD</given-names></name><name><surname>Wang</surname><given-names>RY</given-names></name><etal/></person-group><year>2013</year><article-title>Investigation of residual hepatitis C virus in presumed recovered
subjects</article-title><source>Hepatology</source><volume>57</volume><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">22729600</pub-id></element-citation></ref><ref id="B09"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamaia</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Allain</surname><given-names>JP</given-names></name></person-group><year>2001</year><article-title>The dynamics of hepatitis C virus binding to platelets and 2
mononuclear cell lines</article-title><source>Blood</source><volume>98</volume><fpage>2293</fpage><lpage>2300</lpage><pub-id pub-id-type="pmid">11588022</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levada</surname><given-names>PM</given-names></name><name><surname>Moraes</surname><given-names>CF</given-names></name><name><surname>Corvino</surname><given-names>SM</given-names></name><etal/></person-group><year>2010</year><article-title>Reverse hybridization and sequencing for genotyping the hepatitis
C virus</article-title><source>Rev Soc Bras Med Trop</source><volume>43</volume><fpage>135</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">20464141</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padovani</surname><given-names>JL</given-names></name><name><surname>Corvino</surname><given-names>SM</given-names></name><name><surname>Drexler</surname><given-names>JF</given-names></name><etal/></person-group><year>2013</year><article-title>In vitro detection of hepatitis C virus in platelets from
uninfected individuals exposed to the virus</article-title><source>Rev Soc Bras Med Trop</source><volume>46</volume><fpage>154</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">23559343</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penin</surname><given-names>F</given-names></name><name><surname>Dubuisson</surname><given-names>J</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><etal/></person-group><year>2004</year><article-title>Structural biology of hepatitis C virus</article-title><source>Hepatology</source><volume>39</volume><fpage>5</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">14752815</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehermann</surname><given-names>B</given-names></name></person-group><year>2013</year><article-title>Pathogenesis of chronic viral hepatitis: differential roles of T
cells and NK cells</article-title><source>Nature Medicine</source><volume>19</volume><fpage>859</fpage><lpage>868</lpage></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>WN</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Han</surname><given-names>JQ</given-names></name><etal/></person-group><year>1997</year><article-title>Distribution of Hepatitis C Virus (HCV) RNA in whole blood and
blood cell fractions: plasma HCV RNA analysis underestimates circulating
virus load</article-title><source>J Infec Dis</source><volume>176</volume><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">9207345</pub-id></element-citation></ref></ref-list></back></article>